Download PDF
Journal Club AINS 2013; 2(3): 164-170
DOI: 10.1055/s-0033-1356753
Leitlinien in der Praxis
© Georg Thieme Verlag Stuttgart · New York

Akutes Koronarsyndrom mit persistierender ST-Streckenhebung – Die ESC-Leitlinien in der Praxis

Konstantinos Karatolios
,
Bernhard Schieffer
Further Information

Publication History

Publication Date:
01 October 2013 (online)

Also available at
    Permissions and Reprints

Die Behandlung des akuten Herzinfarkts befindet sich in den letzten Jahren mit der Entwicklung neuer Thrombozytenaggregationshemmer, neuer Antikoagulanzien und insbesondere neuer Stents im stetigen Wandel. Unter diesem Aspekt hat die European Society of Cardiology (ESC) im Oktober 2012 eine überarbeitete Leitlinie zur Diagnose und Behandlung des akuten Myokardinfarkts mit persistierender ST-Streckenhebung (STEMI) veröffentlicht [1], welche die bisherigen Leitlinien aus dem Jahr 2008 ablöst [2]. Diese Übersichtsarbeit soll einen praxisnahen Überblick über die ESC-Leitlinien zur Diagnostik und Behandlung des STEMI geben. Dabei wird hauptsächlich auf die Akutdiagnostik und Akutbehandlung eingegangen.

 

  • Literatur

  • 1 Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC). Steg PG, James SK et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 2012; 33: 2569-2619
    CrossrefPubMedGoogle Scholar
  • 2 Van de Werf F, Bax J, Betriu A et al. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J 2008; 29: 2909-2945
    CrossrefPubMedGoogle Scholar
  • 3 Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 2003; 361: 13-20
    CrossrefPubMedGoogle Scholar
  • 4 Jolly SS, Yusuf S, Cairns J et al. Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial. Lancet 2011; 377: 1409-1420
    CrossrefPubMedGoogle Scholar
  • 5 Romagnoli E, Biondi-Zoccai G, Sciahbasi A et al. Radial versus femoral randomized investigation in ST-segment elevation acute coronary syndrome: the RIFLE-STEACS (Radial Versus Femoral Randomized Investigation in ST-Elevation Acute Coronary Syndrome) study. J Am Coll Cardiol 2012; 60: 2481-2489
    CrossrefPubMedGoogle Scholar
  • 6 Bangalore S, Kumar S, Fusaro M et al. Short- and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed-treatment comparison analysis of 117 762 patient-years of follow-up from randomized trials. Circulation 2012; 125: 2873-2891
    CrossrefGoogle Scholar
  • 7 Palmerini T, Biondi-Zoccai G, Riva Della D et al. Clinical Outcomes with Drug-Eluting and Bare Metal Stents in Patients with ST-Segment Elevation Myocardial Infarction: Evidence from a Comprehensive Network Meta-analysis. J Am Coll Cardiol 2013; 62: 496-504
    CrossrefGoogle Scholar
  • 8 European Heart Rhythm Association, European Association for Cardio-Thoracic Surgery. Camm AJ et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J 2010; 31: 2369-2429
    CrossrefGoogle Scholar
  • 9 Svilaas T, Vlaar PJ, van der Horst IC et al. Thrombus aspiration during primary percutaneous coronary intervention. N Engl J Med 2008; 358: 557-567
    CrossrefPubMedGoogle Scholar
  • 10 Wiviott SD, Braunwald E, McCabe CH et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 2007; 357: 2001-2015
    CrossrefPubMedGoogle Scholar
  • 11 Wallentin L, Becker RC, Budaj A et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 2009; 361: 1045-1057
    CrossrefPubMedGoogle Scholar
  • 12 Stone GW, Witzenbichler B, Guagliumi G et al. Bivalirudin during primary PCI in acute myocardial infarction. N Engl J Med 2008; 358: 2218-2230
    CrossrefPubMedGoogle Scholar
  • 13 Ellis SG, Tendera M, de Belder MA et al. Facilitated PCI in patients with ST-elevation myocardial infarction. N Engl J Med 2008; 358: 2205-2217
    CrossrefGoogle Scholar
  • 14 Berg ten JM, van t Hof AWJ, Dill T et al. Effect of early, pre-hospital initiation of high bolus dose tirofiban in patients with ST-segment elevation myocardial infarction on short- and long-term clinical outcome. J Am Coll Cardiol 2010; 55: 2446-2455
    CrossrefGoogle Scholar
  • 15 Armstrong PW, Gershlick AH, Goldstein P et al. Fibrinolysis or primary PCI in ST-segment elevation myocardial infarction. N Engl J Med 2013; 368: 1379-1387
    CrossrefGoogle Scholar